Rivaroxaban Assay
Rivaroxaban is a new generation oral anticoagulant designed to replace warfarin therapy. The anti-factor Xa assay is used to monitor Rivaroxaban.
| Tube | 05 (CP) - Citrate |
|---|---|
| ID | 12727 |
| Availability | Weekdays |
| Additional Information | Rivaroxaban therapy does not usually require monitoring. Some patients however, may require levels to be monitored. |
| Send to | Specialist Coagulation Chancellor / Lincoln Wing Link Corridor Pathology Block 32 St James University Hospital Beckett Street Leeds LS9 7TF |
| Contact | https://www.leedsth.nhs.uk/a-z-of-services/pathology-2/specialist-laboratory-medicine-slm/specialist-coagulation/?stage=Stage |
| Collection Con | 1 x Citrate tube filled to the line. Samples must be processed within 6 hours of being taken. |
| Sample REQ | Blood |
| Ref. Range Notes | Critical action limit >550ng/mL |
| Units | ng/mL |
| IP Acute TAT | 4 hours from receipt |
| IP Routine TAT | 24 hours |
| GP Acute TAT | Contact laboratory |
| GP Routine TAT | 24 hours |
| Telepath | RIV1J |
| ICE Codes | LRIVA |
